140 related articles for article (PubMed ID: 1915385)
1. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis.
De Wit S; Urbain D; Rahir F; Weerts D; Clumeck N
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):503-5. PubMed ID: 1915385
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS.
Gil A; Lavilla P; Valencia E; Pintado V; Dupla ML; Khamashta MA; García-Puig J; Ortiz-Vázquez J
Postgrad Med J; 1991 Jun; 67(788):548-52. PubMed ID: 1924024
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS.
Laine L; Rabeneck L
Aliment Pharmacol Ther; 1995 Oct; 9(5):553-6. PubMed ID: 8580277
[TBL] [Abstract][Full Text] [Related]
4. [The therapy of Candida esophagitis in AIDS patients with fluconazole].
Heise W; Arasteh K; L'age M
Mycoses; 1990; 33 Suppl 1():32-6. PubMed ID: 2101862
[TBL] [Abstract][Full Text] [Related]
5. Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group.
Barbaro G; Barbarini G; Di Lorenzo G
Chest; 1996 Dec; 110(6):1507-14. PubMed ID: 8989069
[TBL] [Abstract][Full Text] [Related]
6. Short report: time course of clinical response with fluconazole for Candida oesophagitis in patients with AIDS.
Wilcox CM
Aliment Pharmacol Ther; 1994 Jun; 8(3):347-50. PubMed ID: 7918932
[TBL] [Abstract][Full Text] [Related]
7. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study.
Barbaro G; Barbarini G; Di Lorenzo G
Endoscopy; 1995 Jun; 27(5):377-83. PubMed ID: 7588352
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.
Laine L; Dretler RH; Conteas CN; Tuazon C; Koster FM; Sattler F; Squires K; Islam MZ
Ann Intern Med; 1992 Oct; 117(8):655-60. PubMed ID: 1308663
[TBL] [Abstract][Full Text] [Related]
9. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.
Leen CL; Dunbar EM; Ellis ME; Mandal BK
J Infect; 1990 Jul; 21(1):55-60. PubMed ID: 2200826
[TBL] [Abstract][Full Text] [Related]
10. [Candida esophagitis treated with a single dose of fluconazole in patients with HIV: presentation of 11 cases].
Roig P; Martínez A; Salavert M; Nieto A; Navarro V; Medina E; Carrasco R
Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):544-7. PubMed ID: 2099854
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of esophageal candidiasis with fluconazole in acquired immunodeficiency syndrome. Comparative study of 2 therapeutic schemes].
Gil A; Lavilla P; López Dupla M; Valencia E; Pintado V; Khamashta M; García Puig J; Ortiz-Vázquez J
Med Clin (Barc); 1992 Apr; 98(16):612-7. PubMed ID: 1630165
[TBL] [Abstract][Full Text] [Related]
12. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Barbarini G; Di Lorenzo G
Scand J Infect Dis; 1995; 27(6):613-7. PubMed ID: 8685642
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
De Wit S; Weerts D; Goossens H; Clumeck N
Lancet; 1989 Apr; 1(8641):746-8. PubMed ID: 2564563
[TBL] [Abstract][Full Text] [Related]
14. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis.
Vandercam B; Gibbs D; Valtonen M; Jäger H; Armignacco O
J Int Med Res; 1998; 26(4):209-18. PubMed ID: 9818788
[TBL] [Abstract][Full Text] [Related]
16. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
Barbaro G; Di Lorenzo G
Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis.
Villanueva A; Gotuzzo E; Arathoon EG; Noriega LM; Kartsonis NA; Lupinacci RJ; Smietana JM; DiNubile MJ; Sable CA
Am J Med; 2002 Sep; 113(4):294-9. PubMed ID: 12361815
[TBL] [Abstract][Full Text] [Related]
18. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.
Stevens DA; Greene SI; Lang OS
Arch Intern Med; 1991 Dec; 151(12):2458-64. PubMed ID: 1747004
[TBL] [Abstract][Full Text] [Related]
19. [Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS].
Gritti FM; Raise E; Di Salvo S; Vannini V; Lanzoni G; Cucci AM
G Ital Chemioter; 1988; 35(1-3):61-8. PubMed ID: 2855730
[No Abstract] [Full Text] [Related]
20. Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.
Troke PF
Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):287-95. PubMed ID: 9177962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
